Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 09, 2026 0.2345
October 08, 2026 0.2217
October 07, 2026 0.2447
October 06, 2026 0.2751
October 05, 2026 0.2315
October 02, 2026 0.1792
October 01, 2026 0.1933
September 30, 2026 0.2203
September 29, 2026 0.2604
September 28, 2026 0.2947
September 25, 2026 0.3769
September 24, 2026 0.3456
September 23, 2026 0.4361
September 22, 2026 1.687
September 21, 2026 0.1307
September 18, 2026 0.1327
September 17, 2026 0.1346
September 16, 2026 0.171
September 15, 2026 0.1649
September 14, 2026 0.2341
September 11, 2026 0.2306
September 10, 2026 0.2342
September 09, 2026 0.269
September 08, 2026 0.3041
September 04, 2026 0.4382
Date Value
September 03, 2026 0.5099
September 02, 2026 0.5359
September 01, 2026 0.5367
August 31, 2026 0.5809
August 28, 2026 0.5947
August 27, 2026 0.6351
August 26, 2026 0.6751
August 25, 2026 0.6791
August 24, 2026 0.6696
August 21, 2026 0.637
August 20, 2026 0.6414
August 19, 2026 0.6787
August 18, 2026 0.717
August 17, 2026 0.6453
August 14, 2026 0.6726
August 13, 2026 0.575
August 12, 2026 0.558
August 11, 2026 0.5752
August 10, 2026 0.6126
August 07, 2026 0.6976
August 06, 2026 0.6897
August 05, 2026 0.7746
August 04, 2026 0.7342
August 03, 2026 0.7342
July 31, 2026 0.7342

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Omeros Corp. --
ANI Pharmaceuticals, Inc. 2.842
Corcept Therapeutics, Inc. 18.53
Veru, Inc. 1.478
Johnson & Johnson 7.410

Price to Book Value Related Metrics

PS Ratio 0.0045
Price 4.79
Earnings Yield -114.5K%
Market Cap 1.551M